Stage 1 hypertension: SBP 140-159 or DBP 90-99 Stage 2 hypertension ... For patients with hypertension, the basic BP-control target is <140/<90 mm Hg, but the target is <130/<80 mm Hg for patients ...

Participants with uncontrolled and otherwise treatment-resistant hypertension showed significant blood pressure improvement ...

Mineralys is a clinical-stage biopharmaceutical ... from the Phase 2 Advance-HTN trial evaluating the efficacy and safety of lorundrostat for the treatment of uncontrolled hypertension (uHTN ...

What can you do if a patient with hypertension can't control their blood pressure with ... The company is also running the phase 2 Explore-CKD trial of lorundrostat in chronic kidney disease ...

High blood pressure, aka hypertension, can lead to heart disease or stroke if left uncontrolled. Here's what medical experts consider to be high blood pressure, how to know if you have it ...

Consult your healthcare provider if your blood pressure readings consistently fall in the elevated or hypertension stage 1 or 2 categories. High blood pressure often presents without any ...

Significant blood pressure reductions among patients with uncontrolled or resistant hypertension treated with lorundrostat reinforce key role of dy ...

Mineralys Therapeutics on Monday reported positive topline results from a pair of pivotal studies of its lorundrostat drug candidate for the treatment of uncontrolled or resistant hypertension.

The designation targets an estimated U.S. patient population of over 7.7 million with uncontrolled hypertension and increased ... still in the investigational stage and has yet to complete the ...

DelveInsight's "TRYVIO/JERAYGO Market Size, Forecast, and Market Insight Report" highlights the details around TRYVIO/JERAYGO ...